Sign up
Quantellect · Congress · Trade Detail
NASDAQ: NBIXNeurocrine Biosciences Inc
RepublicanHouse

Lisa C. McClain sold Neurocrine Biosciences Inc (NASDAQ: NBIX)

Lisa C. McClain (R-MI), a U.S. Representative, has disclosed 2 trades in Neurocrine Biosciences Inc (NBIX) since 2025, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Lisa C. McClain sold $1,001 - $15,000 of Neurocrine Biosciences Inc (NASDAQ: NBIX) on June 17, 2025. Since that trade, NBIX is up +44.77% against the S&P 500 up +23.48%, an outperformance of +21.29%.

Across these filings, Lisa C. McClain has been a balanced trader of NBIX (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

NBIX trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2025

Lisa C. McClain's NBIX trades vs the price

NBIX is up +44.77% since Lisa C. McClain sold on June 17, 2025, versus +23.48% for the S&P 500.

Performance since this trade

Price change since trade
+44.77%
S&P 500 change since trade
+23.48%
Outperformance vs S&P 500
+21.29%

All Lisa C. McClain NBIX trades

TradedTypeSizeReturnEst. profit
June 17, 2025SELL$124.88+44.77%
June 11, 2025BUY$124.17+45.60%+$4K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Lisa C. McClain & NBIX trading FAQ

Is it legal for Lisa C. McClain to trade Neurocrine Biosciences Inc (NBIX) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Neurocrine Biosciences Inc (NBIX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Lisa C. McClain sell NBIX?

Lisa C. McClain disclosed a sale of $1,001 - $15,000 of Neurocrine Biosciences Inc (NBIX) on June 17, 2025, according to public STOCK Act filings.

How has NBIX performed since Lisa C. McClain's trade?

Since Lisa C. McClain sold NBIX on June 17, 2025, the stock is up +44.77%, versus +23.48% for the S&P 500 over the same period, an outperformance of +21.29%.

How many times has Lisa C. McClain traded NBIX?

Lisa C. McClain has disclosed 2 NBIX trades since 2025 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional NBIX trades?

Quantellect tracks every disclosed congressional trade in Neurocrine Biosciences Inc (NBIX) on the Neurocrine Biosciences Inc congressional trading page, which aggregates filings across all members of Congress.

Lisa C. McClain's NBIX tradesAll congressional filings for Neurocrine Biosciences IncLisa C. McClain's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.